Robert Coffin
Fondatore presso REPLIMUNE GROUP, INC.
Patrimonio netto: 11 M $ in data 30/04/2024
Posizioni attive di Robert Coffin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| REPLIMUNE GROUP, INC. | Direttore/Membro del Consiglio | 01/03/2015 | - |
| Direttore Tecnico/Scientifico/R&S | - | - | |
| Fondatore | 01/03/2015 | - | |
| Amministratore Delegato | 01/03/2015 | 09/01/2020 | |
| Presidente | 01/03/2015 | 01/04/2024 |
Storia della carriera di Robert Coffin
Precedenti posizioni note di Robert Coffin
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Direttore/Membro del Consiglio | 01/01/1999 | 24/01/2013 |
| Direttore Tecnico/Scientifico/R&S | 01/01/1999 | 24/01/2013 | |
| Fondatore | 15/10/2009 | 24/01/2013 | |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2011 | 01/01/2013 |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 01/01/1999 | 04/03/2011 |
| Direttore Tecnico/Scientifico/R&S | 01/01/1999 | 04/03/2011 | |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Direttore/Membro del Consiglio | 01/01/1999 | - |
| Direttore Tecnico/Scientifico/R&S | 01/01/1999 | - | |
| Fondatore | 01/01/1999 | - |
Formazione di Robert Coffin
| Imperial College London | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Regno Unito | 3 |
Posizioni
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 3 |
Settori
| Health Technology | 5 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| REPLIMUNE GROUP, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| Aziende private | 3 |
|---|---|
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
- Borsa valori
- Insiders
- Robert Coffin
- Esperienza
